Amylyx Pharmaceuticals, Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$5.1M
Doctors Paid
1,085
Transactions
3,152
2024 Total
$1.8M
Payment Breakdown by Category
Research$4.4M (87.2%)
Consulting$104,382 (2.1%)
Food & Beverage$75,643 (1.5%)
Travel$43,043 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.4M | 630 | 87.2% |
| Honoraria | $322,131 | 206 | 6.3% |
| Consulting Fee | $104,382 | 18 | 2.1% |
| Space rental or facility fees (teaching hospital only) | $82,900 | 14 | 1.6% |
| Food and Beverage | $75,643 | 2,109 | 1.5% |
| Travel and Lodging | $43,043 | 130 | 0.8% |
| Grant | $22,500 | 2 | 0.4% |
| Education | $1,280 | 43 | 0.0% |
Payments by Type
Research
$4.4M
630 transactions
General
$651,880
2,522 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A35-009 | $1.4M | 0 | 375 |
| Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment (Phoenix) | $1.0M | 0 | 62 |
| A Phase II Study of Safety and Efficacy of AMX0035 in Adult Patients With Wolfram Syndrome | $911,085 | 0 | 36 |
| An Intermediate Size Expanded Access Protocol of AMX0035 for ALS | $638,012 | 0 | 31 |
| Single cohort Real World Experience with Relyvrio for ALS: A Retrospective Chart Review | $221,000 | 0 | 5 |
| A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Safety and Efficacy of AMX0035 Versus Placebo for 48-week Treatment of Adult Patients with Amyotrophic Lateral Sclerosis (ALS) | $158,600 | 0 | 52 |
| A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF AMX0035 VERSUS PLACEBO FOR 48-WEEK TREATMENT OF ADULT PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS (ALS) | $120,923 | 0 | 60 |
| A Pharmacokinetic and Pharmacodynamic Study of AMX0035 in Patients With ALS | $14,144 | 0 | 3 |
| Phase III Trial of AMX0035 for Amyotrophic Lateral Sclerosis Treatment (Phoenix) | $7,451 | 0 | 1 |
| A35-004 | $6,001 | 0 | 5 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Sabrina Paganoni, Md, Phd, MD, PHD | Neuromuscular Medicine | Charlestown, MA | $73,636 | $0 |
| Gary Pattee, M.d, M.D | Neurology | Lincoln, NE | $58,975 | $0 |
| Jeffrey Rosenfeld, Md, MD | Clinical Neurophysiology | Fresno, CA | $36,081 | $0 |
| Lauren Brown, Np, NP | Gerontology | Portland, OR | $26,062 | $0 |
| Dr. Richard Bedlack, M.d. Ph.d, M.D. PH.D | Neurology | Durham, NC | $21,780 | $0 |
| John Novak, M.d, M.D | Neurology | Westerville, OH | $19,799 | $0 |
| Said Beydoun, M.d, M.D | Neurology | Los Angeles, CA | $16,445 | $0 |
| Dr. Michael Elliott, Md, MD | Neurology | Seattle, WA | $15,542 | $0 |
| Jinae Arneklev, Crnp, CRNP | Family | Baltimore, MD | $15,320 | $0 |
| Dr. Nithya Mathai, Dnp,Fnp-C, DNP,FNP-C | Nurse Practitioner | Boynton Beach, FL | $13,694 | $0 |
| Jourdan Milliard, Fnp-C, FNP-C | Family | Phoenix, AZ | $11,883 | $0 |
| Terry Heiman-Patterson, Md, MD | Neurology | Philadelphia, PA | $11,419 | $0 |
| Ms. Jerrica Farias | Nurse Practitioner | Tampa, FL | $11,337 | $0 |
| Daragh Heitzman, M.d, M.D | Neurology | Dallas, TX | $10,337 | $0 |
| Jeremy Shefner, M.d, M.D | Neurology | Phoenix, AZ | $9,043 | $0 |
| Dr. Rup Tandan, M.d., Frcp, M.D., FRCP | Neurology | Burlington, VT | $8,153 | $0 |
| Zachary Simmons, Md, MD | Clinical Neurophysiology | Hershey, PA | $8,099 | $0 |
| Dr. James Grogan, M.d, M.D | Neurology | Hershey, PA | $5,604 | $0 |
| Dr. Anthony Lembo, M.d, M.D | Gastroenterology | Boston, MA | $5,250 | $0 |
| Dr. Jinsy Andrews, M.d, M.D | Neurology | New York, NY | $4,968 | $0 |
| Dr. James Berry, M.d., M.p.h, M.D., M.P.H | Neurology | Boston, MA | $4,725 | $0 |
| Prof. Erik Pioro, Md, Phd, MD, PHD | Neuromuscular Medicine | Chicago, IL | $4,379 | $0 |
| Tanya Geist, Rpa-C, RPA-C | Surgical | Amherst, NY | $4,319 | $0 |
| Dr. Gustavo Alameda, Md, MD | Neurology | Fort Lauderdale, FL | $4,199 | $0 |
| Brandi Martin, Arpn, Fnp, ARPN, FNP | Nurse Practitioner | Texarkana, TX | $3,870 | $0 |
About Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. has made $5.1M in payments to 1,085 healthcare providers, recorded across 3,152 transactions in the CMS Open Payments database. In 2024, the company paid $1.8M. The top product by payment volume is RELYVRIO ($5.1M).
Payments were distributed across 68 medical specialties. The top specialty by payment amount is Neurology ($245,946 to 437 doctors).
Payment categories include: Food & Beverage ($75,643), Consulting ($104,382), Research ($4.4M), Travel & Lodging ($43,043).
Amylyx Pharmaceuticals, Inc. is associated with 1 products in the CMS Open Payments database.